期刊文献+

Ⅲ期肺鳞癌后加速超分割三维适形放疗协同化疗的远期疗效和预后分析 被引量:7

原文传递
导出
摘要 Ⅲ期非小细胞肺癌以综合治疗为主,2年生存率只有27.3%左右^[1]。而三维适形放疗(3DCRT)、后加速超分割放疗、每周小剂量紫杉醇同步放化疗可提高中晚期肺鳞癌的局部控制率和生存率^[2-4]。笔者进行了Ⅲ期肺鳞癌后加速超分割3DCRT协同化疗的临床I和Ⅱ期随机分组试验,现将远期疗效和预后分析结果报道如下。
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2008年第2期134-135,共2页 Chinese Journal of Radiation Oncology
  • 相关文献

参考文献5

二级参考文献19

  • 1张恩宁,张淑玲,付爱芹,曲维庆.三维适形放疗和化疗同步治疗非小细胞肺癌临床分析[J].中国肿瘤临床与康复,2005,12(3):218-220. 被引量:7
  • 2张湘茹,孙燕.紫杉醇治疗非小细胞肺癌[J].中国新药杂志,1996,5(4):245-248. 被引量:31
  • 3王毓洲,郭胤仕,邢祖林.足叶乙甙、顺氯氨铂联合胸部放疗治疗局限性晚期肺鳞癌疗效观察[J].中国肿瘤临床,1996,23(10):700-703. 被引量:9
  • 4陈东福.肺癌[A].见:殷蔚伯 谷铣之主编.肿瘤放射治疗学[C].北京:中国协和医科大学出版社,2002.623-649.
  • 5Cox JD,Stetz J,Pajak TF.Toxcity criteria of the Radiation Therapy Oncology Group(RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).Int J Radiat Oncol Biol Phys,1995,31:1341-1346.
  • 6Nishuimura Y,Ono K,Tsutsui K,et al.Esophageal cancer treated with radioth erapy:impact of total treatment time and fractionation.Int J Radit Oncol Biol P hys,1994,30:1099-1105.
  • 7Socinski MA,Rosenman JG.Chemotherapeutic issues in the management of unresectable stage Ⅲ non-small cell lung cancer.Semin Oncol,2005,32 (2 Suppl 3):S18-24.
  • 8Steven E,Schild M,Philip J,et al.Phase Ⅲ trial comparing chemotherapy plus once-daily twice-daily radiotherapy in stage Ⅲ non-small cell lung cancer.Int J Radial Oncol Biol Phys,2002,54:370-378.
  • 9Ohe Y.Chemoradiotherapy for lung cancer:current status and perspectives.Int J Clin Oncol,2004,9:435 -443.
  • 10Penland SK,Socinski MA.Management of unresectable stage Ⅲ non -small cell lung cancer:the role of combined chemoradiation.Semin Radiat Oncol,2004,14:326-334.

共引文献64

同被引文献43

  • 1李承军,徐利明.肺癌放疗中活动靶区常规CT定位和PET/CT定位的模体研究比较[J].中国医学物理学杂志,2011,28(4):2743-2749. 被引量:8
  • 2于会明,于金明,刘运芳,赵献光,马丽.氟脱氧葡萄糖正电子发射型体层摄影术在非小细胞肺癌适形放疗中的应用研究[J].中华放射肿瘤学杂志,2005,14(2):105-107. 被引量:7
  • 3王凯,王绿化,梁军,欧广飞,吕纪马.FDG PET对非小细胞肺癌合并肺不张三维适形放疗时靶区确定的临床意义[J].中华放射肿瘤学杂志,2006,15(1):11-14. 被引量:27
  • 4Sause W, Kolesar P, Taylor Ⅳ S, et al. Final results of phase Ⅲ trial in regionally advanced unresectable non-small cell lung cancer. Radiation Therapy Oncology, Eastern Cooperative Ontology Group, and Southwest Oncology Group. Chest, 2000, 117(2):358-364.
  • 5Belderbos J, Uitterhoeve L, van Zandwijk N, et al. EORTC LCG and RT Group. Randomised trial of sequential versus concurrent chemoradiotherapy in patients with inoperable non-small cell lung cancer ( EORTC 08972-22973). Eur J Cancer, 2007, 43 ( 1 ) : 114-121.
  • 6Naito Y, Kubota K, Nihei K, et al. Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage Ⅲ non-small cell lung cancer. J Thorac Oncol, 2008, 3 (6) :617-622.
  • 7Hirsh V, Soulieres D, Duclos M, et al. Phase Ⅱ muhicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage Ⅲ A and Ⅲ B non-small cell lung cancer. J Thorac Oncol, 2007, 2(10) :927-932.
  • 8Vokes EE, Herndon JE, Crawford J, et al. Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage Ⅲ non-small-cell lung cancer: Cancer and Leukemia Group B. J Clin Oncol, 2007, 25 (13) :1698-1704.
  • 9Choong NW, Vokes EE, Haraf DJ et al. Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage Ⅲ non-small cell lung cancer. J Thorac Oncol, 2008, 3( 1 ) :59-67.
  • 10Huang EH, Liao Z, Gox TM, et al. Comparison of outcomes for patients with unresectable, Locally advanced non-small-cell lung cancer treated with Induction chemotherapy followed by concurrent Chemoradiation vs. Concurrent chemoradiation alone. Int J Radiat Oncol Biol Phys, 2007, 68(3) :779-785.

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部